Tibet Duo Rui Pharmaceutical: 2024/04/25 Investor Relations Activity Schedule
Dorui Pharmaceuticals: Announcement of Resolutions of the 12th Meeting of the 2nd Board of Supervisors
Dorui Pharmaceuticals: An indicative announcement on the disclosure of the report for the first quarter of 2024
Dorui Pharmaceuticals: Announcement of Resolutions of the 12th Meeting of the 2nd Board of Directors
Dorui Pharmaceuticals: Entrusted Financial Management System
Dorui Pharmaceuticals: Supervisory Board Opinions on Matters Related to the 12th Meeting of the 2nd Board of Supervisors
Dorui Pharmaceuticals: Management System for the Submission and Use of External Information
Dorui Pharmaceuticals: Report for the first quarter of 2024
Dorui Pharmaceuticals: Announcement on holding the 2023 Online Results Briefing
Dorui Pharmaceuticals: Announcement on the 2023 Profit Distribution Plan
Dorui Pharmaceuticals: The Board\'s Special Opinion on the Independent Director\'s Assessment
Dorui Pharmaceuticals: Annual Storage and Use Verification Report of Raised Funds
Dorui Pharmaceuticals: Announcement to amend the company\'s articles of association
Dorui Pharmaceuticals: Supervisory Board Opinions on Matters Related to the 11th Meeting of the 2nd Board of Supervisors
Dorui Pharmaceuticals: Articles of Association
Dorui Pharmaceutical: CITIC Securities Co., Ltd.'s special inspection opinion on the storage and use of funds raised by Tibet Dorui Pharmaceutical Co., Ltd. in 2023
Dorui Pharmaceuticals: Special Audit Instructions for 2023 Dorui Pharmaceutical\'s Non-Operating Capital Occupation and Other Related Fund Transactions
Dorui Pharmaceuticals: Announcement on the confirmation of daily related transactions in 2023
Dorui Pharmaceuticals: Independent Director\'s 2023 Debriefing Report (Liu Yingfei)
Dorui Pharmaceutical: CITIC Securities Co., Ltd.\'s inspection opinion on the confirmation of daily related transactions of Tibet Dorui Pharmaceutical Co., Ltd. in 2023
No Data